✦ LIBER ✦

Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin

✍ Scribed by Frank C. Bekkering; Johannes T. Brouwer; Bettina E. Hansen; Solko W. Schalm

Book ID: 119525456
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 135 KB
Volume: 34
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(00)00033-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of ribavirin on hepatitis C viral

Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon

✍ Eva Herrmann; Jung-Hun Lee; George Marinos; Marlene Modi; Stefan Zeuzem 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

High sustained virological response in d

High sustained virological response in difficult to treat hepatitis C patients by combination of daily high dose and prolonged maintenance interferon-ribavirin therapy

✍ F.C. Bekkering; J.T. Brouwer; B.E. Hansen; H.G.M. Niesters; S.W. Schalm 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Early hepatitis C viral kinetics correla

Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy

✍ Hugo R. Rosen; Ruy R. Ribeiro; Leor Weinberger; Stephanie Wolf; Minjun Chung; Da 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 135 KB

High viral response rates in previous no

High viral response rates in previous nonresponder patients with hepatitis C treated with daily dosing of consensus interferon and ribavirin

✍ Stephan Kaiser; Christian Kreysel; Holger Hass; Michael Gregor 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Depressive symptoms and viral clearance

Depressive symptoms and viral clearance in patients receiving interferon-α and ribavirin for hepatitis C

✍ Charles L. Raison; Sherry D. Broadwell; Andrey S. Borisov; Amita K. Manatunga; L 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Hepatitis C treatment in “difficult-to-t

Hepatitis C treatment in “difficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects

✍ Martin Schaefer; Axel Hinzpeter; Ariane Mohmand; Gesa Janssen; Maurice Pich; Mar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

We investigated and compared the results of treating the chronic hepatitis C (HCV) infection of different groups of psychiatric-risk patients and controls with pegylated interferon alpha (pe-gIFN-␣) plus ribavirin. Seventy patients were prospectively screened for psychiatric disorders. Seventeen pat